+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Drug Testing Market Size, Share & Trends Analysis Report by Product Type (Consumables, Instruments, Rapid Testing Devices, Services), by Sample Type, by Drug Type, by End Use, by Region, and Segment Forecasts, 2021-2028

  • ID: 5415568
  • Report
  • May 2021
  • Region: Global
  • 120 Pages
  • Grand View Research

FEATURED COMPANIES

  • Abbott
  • Cordant Health Solutions
  • Drägerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche
  • Omega Laboratories, Inc.
  • Quidel Corporation
The global drug testing market size is expected to reach USD 11.7 billion by 2028. It is expected to expand at a CAGR of 4.9% from 2021 to 2028. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period.



Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.

For instance, in June 2019, Quidel Corporation received the U.S. FDA’s 510(k) clearance to market its fluorescence immunoassay-Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing to help courts & government agencies to monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.

Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power to conduct random roadside drug testing of drivers to reduce impaired driving in the country. The new bill allows usage of oral fluid tests to check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis to ensure safe air travel.

Drug Testing Market Report Highlights

  • By product type, the consumables segment dominated the market in 2020, owing to its repetitive use to conduct substance abuse screening
  • Based on sample type, the urine samples segment accounted for the largest revenue share in 2020, as it is the most common method of sample collection
  • Increased unemployment and economic crisis due to the Covid-19 pandemic has made people more susceptible to substance abuse, thus created lucrative opportunities in the market
  • The legalization of marijuana for medicinal as well as recreational use in several countries is anticipated to change the current scenario and may create demand for innovative testing solutions
  • Stringent privacy rights in some countries are likely to limit substance abuse testing at workplaces, impeding market growth
  • In Asia Pacific, the market is expected to witness lucrative growth over the forecast period as a result of the growing demand for substance abuse testing from emerging economies, such as China and India
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Cordant Health Solutions
  • Drägerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche
  • Omega Laboratories, Inc.
  • Quidel Corporation
Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Drug Testing Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Stringent laws mandating alcohol and drug testing
3.3.1.2 Increase in government initiatives to monitor substance abuse
3.3.1.3 High prevalence of substance abuse
3.3.2 Market Restraint Analysis
3.3.2.1 Drug testing is considered a violation of privacy rights in some countries
3.3.3 Market Opportunity Analysis
3.3.3.1 Focus on development of innovative testing solutions
3.4 Drug Testing Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Substitution Threat
3.4.1.4 Threat from new entrants
3.4.1.5 Competitive Rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Environmental Landscape
3.4.2.3 Social landscape
3.4.2.4 Application landscape
3.4.2.5 Legal Landscape

Chapter 4 Drug Testing Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.3 Public Companies
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis

Chapter 5 Drug Testing Market: Product Type Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Product Type Market Share Analysis, 2020 & 2028
5.3 Segment Dashboard
5.4 Global Drug Testing Market, by Product Type, 2016 to 2028
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2028
5.5.1 Consumables
5.5.1.1 Consumables Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.2 Instruments
5.5.2.1 Instruments Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.3 Rapid Testing Devices
5.5.3.1 Rapid Testing Devices Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.4 Services
5.5.4.1 Services Market Estimates and Forecasts, 2016 to 2028 (USD Million)

Chapter 6 Drug Testing Market: Sample Type Estimates And Trend Analysis
6.1 Definition & Scope
6.2 Sample Type Market Share Analysis, 2020 & 2028
6.3 Segment Dashboard
6.4 Global Drug Testing Market, by Sample Type, 2016 to 2028
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2028
6.5.1 Urine Samples
6.5.1.1 Urine Samples Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.2 Oral Fluid Samples
6.5.2.1 Oral Fluid Samples Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.3 Hair Samples
6.5.3.1 Hair Samples Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.4 Other Samples
6.5.4.1 Other Samples Market Estimates and Forecasts, 2016 to 2028 (USD Million)

Chapter 7 Drug Testing Market: Drug Type Estimates And Trend Analysis
7.1 Definition & Scope
7.2 Drug Type Market Share Analysis, 2020 & 2028
7.3 Segment Dashboard
7.4 Global Drug Testing Market, by Drug Type, 2016 to 2028
7.5 Market Size & Forecasts and Trend Analyses, 2016 to 2028
7.5.1 Alcohol
7.5.1.1 Alcohol Market Estimates and Forecasts, 2016 to 2028 (USD Million)
7.5.2 Cannabis/Marijuana
7.5.2.1 Cannabis/Marijuana Market Estimates and Forecasts, 2016 to 2028 (USD Million)
7.5.3 Cocaine
7.5.3.1 Cocaine Market Estimates and Forecasts, 2016 to 2028 (USD Million)
7.5.4 Opioids
7.5.4.1 Opioids Samples Market Estimates and Forecasts, 2016 to 2028 (USD Million)
7.5.5 Amphetamine & Methamphetamine
7.5.5.1 Amphetamine & Methamphetamine Market Estimates and Forecasts, 2016 to 2028 (USD Million)
7.5.6 LSD
7.5.6.1 LSD Market Estimates and Forecasts, 2016 to 2028 (USD Million)
7.5.7 Others
7.5.7.1 Others Market Estimates and Forecasts, 2016 to 2028 (USD Million)

Chapter 8 Drug Testing Market: End-use Estimates And Trend Analysis
8.1 Definition & Scope
8.2 End-use Market Share Analysis, 2020 & 2028
8.3 Segment Dashboard
8.4 Global Drug Testing Market, by End Use, 2016 to 2028
8.5 Market Size & Forecasts and Trend Analyses, 2016 to 2028
8.5.1 Drug Testing Laboratories
8.5.1.1 Drug Testing Laboratories Market Estimates and Forecasts, 2016 to 2028 (USD Million)
8.5.2 Workplaces
8.5.2.1 Workplaces Market Estimates and Forecasts, 2016 to 2028 (USD Million)
8.5.3 Hospitals
8.5.3.1 Hospitals Market Estimates and Forecasts, 2016 to 2028 (USD Million)
8.5.4 Others
8.5.4.1 Others Market Estimates and Forecasts, 2016 to 2028 (USD Million)

Chapter 9 Drug Testing Market: Regional Estimates & Trend Analysis
9.1 Regional Market Snapshot
9.2 Regional Market Share and Leading Players, 2020
9.2.1 North America
9.2.2 Europe
9.2.3 Latin America
9.2.4 Asia Pacific
9.2.5 Middle East & Africa
9.3 Market Share Analysis by Country, 2020
9.3.1 North America
9.3.1.1 U.S.
9.3.1.2 Canada
9.3.2 Europe
9.3.2.1 U.K.
9.3.2.2 Germany
9.3.2.3 Spain
9.3.2.4 France
9.3.2.5 Italy
9.3.3 Latin America
9.3.3.1 Brazil
9.3.3.2 Mexico
9.3.3.3 Chile
9.3.4 Asia Pacific
9.3.4.1 Japan
9.3.4.2 China
9.3.4.3 India
9.3.5 Middle East & Africa
9.3.5.1 South Africa
9.3.5.2 Saudi Arabia
9.3.5.3 UAE
9.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
9.4.1 North America
9.4.2 Europe
9.4.3 Latin America
9.4.4 Asia Pacific
9.4.5 Middle East & Africa
9.5 Market Size & Forecasts, and Trend Analysis, 2020 to 2028
9.5.1 North America
9.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
9.5.1.2 U.S.
9.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.1.2.2 U.S. Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.1.2.3 U.S. Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.1.2.4 U.S. Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.1.3 Canada
9.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.1.3.2 Canada Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.1.3.3 Canada Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.1.3.4 Canada Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.2 Europe
9.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
9.5.2.2 U.K.
9.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.2.2.2 U.K. Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.2.2.3 U.K. Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.2.2.4 U.K. Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.2.3 Germany
9.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.2.3.2 Germany Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.2.3.3 Germany Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.2.3.4 Germany Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.2.4 Spain
9.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.2.4.2 Spain Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.2.4.3 Spain Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.2.4.4 Spain Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.2.5 France
9.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.2.5.2 France Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.2.5.3 France Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.2.5.4 France Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.2.6 Italy
9.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.2.6.2 Italy Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.2.6.3 Italy Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.2.6.4 Italy Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.3 Latin America
9.5.3.1 Latin America Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
9.5.3.2 Brazil
9.5.3.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.3.2.2 Brazil Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.3.2.3 Brazil Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.3.2.4 Brazil Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.3.3 Mexico
9.5.3.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.3.3.2 Mexico Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.3.3.3 Mexico Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.3.3.4 Mexico Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.3.4 Chile
9.5.3.4.1 Chile Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.3.4.2 Chile Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.3.4.3 Chile Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.3.4.4 Chile Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.4 Asia Pacific
9.5.4.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
9.5.4.2 Japan
9.5.4.2.1 Japan Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.4.2.2 Japan Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.4.2.3 Japan Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.4.2.4 Japan Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.4.3 China
9.5.4.3.1 China Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.4.3.2 China Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.4.3.3 China Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.4.3.4 China Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.4.4 India
9.5.4.4.1 India Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.4.4.2 India Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.4.4.3 India Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.4.4.4 India Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.5 Middle East & Africa
9.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
9.5.5.2 South Africa
9.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.5.2.2 South Africa Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.5.2.3 South Africa Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.5.2.4 South Africa Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.5.3 Saudi Arabia
9.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.5.3.2 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.5.3.3 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.5.3.4 Saudi Arabia Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)
9.5.5.4 UAE
9.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2028 (USD million)
9.5.5.4.2 UAE Market Size & Forecasts and Trend Analysis, By Sample Type, 2016 to 2028 (USD million)
9.5.5.4.3 UAE Market Size & Forecasts and Trend Analysis, By Drug Type, 2016 to 2028 (USD million)
9.5.5.4.4 UAE Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD million)

Chapter 10 Company Profiles
10.1 Company Profiles
10.1.1 Quest Diagnostics Incorporated
10.1.1.1 Company overview
10.1.1.2 Financial Performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 Abbott
10.1.2.1 Company overview
10.1.2.2 Financial Performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 Quidel Corporation
10.1.3.1 Company overview
10.1.3.2 Financial Performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 F. Hoffmann-La Roche
10.1.4.1 Company overview
10.1.4.2 Financial Performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 Thermo Fisher Scientific, Inc.
10.1.5.1 Company overview
10.1.5.2 Financial Performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 Siemens Healthineers
10.1.6.1 Company overview
10.1.6.2 Financial Performance
10.1.6.3 Product benchmarking
10.1.6.4 Strategic initiatives
10.1.7 Bio-Rad Laboratories, Inc.
10.1.7.1 Company overview
10.1.7.2 Financial Performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 Agilent Technologies, Inc.
10.1.8.1 Company overview
10.1.8.2 Financial Performance
10.1.8.3 Product benchmarking
10.1.8.4 Strategic initiatives
10.1.9 Laboratory Corporation Of America Holdings (Labcorp)
10.1.9.1 Company overview
10.1.9.2 Financial Performance
10.1.9.3 Product benchmarking
10.1.9.4 Strategic initiatives
10.1.10 Drägerwerk AG & Co. KGaA
10.1.10.1 Company overview
10.1.10.2 Financial Performance
10.1.10.3 Product benchmarking
10.1.10.4 Strategic initiatives
10.1.11 Clinical Reference Laboratory, Inc.
10.1.11.1 Company overview
10.1.11.2 Financial Performance
10.1.11.3 Product benchmarking
10.1.11.4 Strategic initiatives
10.1.12 Cordant Health Solutions
10.1.12.1 Company overview
10.1.12.2 Financial Performance
10.1.12.3 Product benchmarking
10.1.12.4 Strategic initiatives
10.1.13 Legacy Medical Services, LLC.
10.1.13.1 Company overview
10.1.13.2 Financial Performance
10.1.13.3 Product benchmarking
10.1.13.4 Strategic initiatives
10.1.14 Omega Laboratories, Inc.
10.1.14.1 Company overview
10.1.14.2 Financial Performance
10.1.14.3 Product benchmarking
10.1.14.4 Strategic initiatives

List of Tables
Table 1 List secondary sources
Table 2 North America drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 3 North America drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 4 North America drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 5 North America drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 6 U.S. drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 7 U.S. drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 8 U.S. drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 9 U.S. drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 10 Canada drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 11 Canada drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 12 Canada drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 13 Canada drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 14 Europe drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 15 Europe drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 16 Europe drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 17 Europe drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 18 Germany drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 19 Germany drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 20 Germany drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 21 Germany drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 22 U.K. drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 23 U.K. drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 24 U.K. drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 25 U.K. drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 26 France drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 27 France drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 28 France drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 29 France drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 30 Italy drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 31 Italy drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 32 Italy drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 33 Italy drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 34 Spain drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 35 Spain drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 36 Spain drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 37 Spain drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 38 Asia Pacific drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 39 Asia Pacific drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 40 Asia Pacific drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 41 Asia Pacific drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 42 Japan drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 43 Japan drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 44 Japan drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 45 Japan drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 46 China drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 47 China drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 48 China drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 49 China drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 50 India drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 51 India drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 52 India drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 53 India drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 54 Latin America drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 55 Latin America drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 56 Latin America drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 57 Latin America drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 58 Brazil drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 59 Brazil drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 60 Brazil drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 61 Brazil drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 62 Mexico drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 63 Mexico drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 64 Mexico drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 65 Mexico drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 66 Chile drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 67 Chile drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 68 Chile drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 69 Chile drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 70 MEA drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 71 MEA drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 72 MEA drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 73 MEA drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 74 South Africa drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 75 South Africa drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 76 South Africa drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 77 South Africa drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 78 Saudi Arabia drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 79 Saudi Arabia drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 80 Saudi Arabia drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 81 Saudi Arabia drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)
Table 82 UAE drug testing market estimates and forecasts, by product type, 2016 - 2028 (USD Million)
Table 83 UAE drug testing market estimates and forecasts, by sample type, 2016 - 2028 (USD Million)
Table 84 UAE drug testing market estimates and forecasts, by drug type, 2016 - 2028 (USD Million)
Table 85 UAE drug testing market estimates and forecasts, by end use, 2016 - 2028 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot, 2020 (USD Million)
Fig. 9 Drug testing market segmentation
Fig. 10 Penetration & growth prospect mapping for product type, 2020
Fig. 11 Penetration & growth prospect mapping for sample type, 2020
Fig. 12 Penetration & growth prospect mapping for drug type, 2020
Fig. 13 Penetration & growth prospect mapping for end use, 2020
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Industry challenges
Fig. 17 Company/competition categorization (key innovators, market leaders, emerging players)
Fig. 18 Strategy framework
Fig. 19 Market participation categorization
Fig. 20 Company position analysis
Fig. 21 Drug testing market: Product type outlook and key takeaways
Fig. 22 Drug testing market: Product type movement analysis
Fig. 23 Consumables market, 2016 - 2028 (USD Million)
Fig. 24 Instruments market, 2016 - 2028 (USD Million)
Fig. 25 Rapid testing devices market, 2016 - 2028 (USD Million)
Fig. 26 Services market, 2016 - 2028 (USD Million)
Fig. 27 Drug testing market: Sample type outlook and key takeaways
Fig. 28 Drug Testing market: Sample type movement analysis
Fig. 29 Urine samples market, 2016 - 2028 (USD Million)
Fig. 30 Oral fluid samples market, 2016 - 2028 (USD Million)
Fig. 31 Hair samples market, 2016 - 2028 (USD Million)
Fig. 32 Other samples market, 2016 - 2028 (USD Million)
Fig. 33 Drug Testing market: Drug type outlook and key takeaways
Fig. 34 Drug Testing market: Drug type movement analysis
Fig. 35 Alcohol market, 2016 - 2028 (USD Million)
Fig. 36 Cannabis/marijuana market, 2016 - 2028 (USD Million)
Fig. 37 Cocaine market, 2016 - 2028 (USD Million)
Fig. 38 Opioids market, 2016 - 2028 (USD Million)
Fig. 39 Amphetamine & methamphetamine market, 2016 - 2028 (USD Million)
Fig. 40 LSD market, 2016 - 2028 (USD Million)
Fig. 41 Others market, 2016 - 2028 (USD Million)
Fig. 42 Drug testing market: End-use outlook and key takeaways
Fig. 43 Drug testing market: End-use movement analysis
Fig. 44 Drug testing laboratories market, 2016 - 2028 (USD Million)
Fig. 45 Workplaces market, 2016 - 2028 (USD Million)
Fig. 46 Hospitals market, 2016 - 2028 (USD Million)
Fig. 47 Others market, 2016 - 2028 (USD Million)
Fig. 48 Drug Testing market: Regional outlook and key takeaways
Fig. 49 Drug Testing market: Regional movement analysis
Fig. 50 North America
Fig. 51 North America drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 52 U.S.
Fig. 53 U.S. drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 54 Canada
Fig. 55 Canada drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 56 Europe
Fig. 57 Europe drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 58 Germany
Fig. 59 Germany drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 60 U.K.
Fig. 61 U.K. drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 62 France
Fig. 63 France drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 64 Italy
Fig. 65 Italy drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 66 Spain
Fig. 67 Spain drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 68 Asia Pacific
Fig. 69 Asia Pacific drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 70 Japan
Fig. 71 Japan drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 72 China
Fig. 73 China drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 74 India
Fig. 75 India drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 76 Latin America
Fig. 77 Latin America drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 78 Brazil
Fig. 79 Brazil drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 80 Mexico
Fig. 81 Mexico drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 82 Chile
Fig. 83 Chile drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 84 MEA
Fig. 85 MEA drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 86 South Africa
Fig. 87 South Africa drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 88 Saudi Arabia
Fig. 89 Saudi Arabia drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 90 UAE
Fig. 91 UAE drug testing market estimates and forecast, 2016 - 2028 (USD Million)
Note: Product cover images may vary from those shown
  • Quest Diagnostics Incorporated
  • Abbott
  • Quidel Corporation
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthineers
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Laboratory Corporation Of America Holdings (Labcorp)
  • Drägerwerk AG & Co. KGaA
  • Clinical Reference Laboratory, Inc.
  • Cordant Health Solutions
  • Legacy Medical Services, LLC.
  • Omega Laboratories, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll